Bio Path reported 0.65 in PE Price to Earnings for its fiscal quarter ending in March of 2025.





Pe Change Date
Baxter International 151.95 65.95 Jun/2026
Cipla 35.82 12.26 Jun/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.45 1.39 Mar/2026
CSL 16.16 9.59 Dec/2025
Grifols 11.2 1.08 Dec/2025